INVENTORY	12 Months Ended
Dec. 31, 2020
Inventory Disclosure [Abstract]
INVENTORY	NOTE 3 – INVENTORY During 2019, inventory consisted of raw material and finished goods stated at the lower of cost or net realizable value with cost determined on a first-in, first-out basis. The Company reviewed the composition of inventory at each reporting period in order to identify obsolete, slow-moving, quantities in excess of expected demand, or otherwise non-saleable items. During the year ended December 31, 2019, the Company recorded a related charge to cost of goods sold for obsolete inventory of $26,000. In addition, the Company’s recognized approximately $456,000 for inventory impairment during the year ended December 31, 2019. The loss on impairment was due to the Company’s strategic decision to discontinue the sale and commercialization of Prestalia. No loss on impairment was recognized for the year ended December 31, 2020.

INVENTORY

12 Months Ended

Dec. 31, 2020

NOTE 3 – INVENTORY

During 2019, inventory consisted of raw material and finished goods stated at the lower of cost or net realizable value with cost determined on a first-in, first-out basis. The Company reviewed the composition of inventory at each reporting period in order to identify obsolete, slow-moving, quantities in excess of expected demand, or otherwise non-saleable items.

During the year ended December 31, 2019, the Company recorded a related charge to cost of goods sold for obsolete inventory of $26,000. In addition, the Company’s recognized approximately $456,000 for inventory impairment during the year ended December 31, 2019. The loss on impairment was due to the Company’s strategic decision to discontinue the sale and commercialization of Prestalia. No loss on impairment was recognized for the year ended December 31, 2020.